<SEC-DOCUMENT>0001013762-23-005862.txt : 20231023
<SEC-HEADER>0001013762-23-005862.hdr.sgml : 20231023
<ACCEPTANCE-DATETIME>20231023170904
ACCESSION NUMBER:		0001013762-23-005862
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20231023
FILED AS OF DATE:		20231023
DATE AS OF CHANGE:		20231023

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MDxHealth SA
		CENTRAL INDEX KEY:			0001872529
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C9

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40996
		FILM NUMBER:		231340522

	BUSINESS ADDRESS:	
		STREET 1:		CAP BUSINESS CENTER
		STREET 2:		RUE D'ABHOOZ, 31, B-4040
		CITY:			HERSTAL
		STATE:			C9
		ZIP:			00000
		BUSINESS PHONE:		949-271-9221

	MAIL ADDRESS:	
		STREET 1:		CAP BUSINESS CENTER
		STREET 2:		RUE D'ABHOOZ, 31, B-4040
		CITY:			HERSTAL
		STATE:			C9
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MDx Health SA
		DATE OF NAME CHANGE:	20210713
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea187081-6k_mdxhealth.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of October 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number 001-40996</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MDXHEALTH SA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CAP Business Center</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Zone Industrielle des Hauts-Sarts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">4040 Herstal, Belgium</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">+32 4 257 70 21</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F &#9746; Form 40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MDXHEALTH SA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On October 20, 2023, MDxHealth SA (the &ldquo;Company&rdquo;) issued
a press release, a copy of which is attached hereto as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>The information in the attached
Exhibit 99.1 is being furnished and shall not be deemed &ldquo;filed&rdquo; for the purposes of Section&nbsp;18 of the Securities Exchange
Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), or otherwise subject to the liabilities of that Section, nor shall it be deemed
incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except
as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 91%; border-bottom: black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description of Exhibit</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea187081ex99-1_mdxhealth.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated October 20, 2023</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MDXHEALTH SA</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: October 23, 2023</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michael McGarrity</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael McGarrity</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea187081ex99-1_mdxhealth.htm
<DESCRIPTION>PRESS RELEASE, DATED OCTOBER 20, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: left; margin: 0"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>NEWS RELEASE - REGULATED
INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>October 20, 2023, 4:00 PM EDT / 22:00 CET</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Mdxhealth&rsquo;s New Share Capital Amount </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>and New Number of Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IRVINE, CA, and HERSTAL, BELGIUM</B> &ndash;
October 20, 2023 &ndash; MDxHealth SA (NASDAQ/Euronext: MDXH) (&ldquo;<B>mdxhealth</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;), a commercial-stage
precision diagnostics company, today a announces, in accordance with Article 15 of the Belgian Act of May 2, 2007 on the disclosure of
major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions,
that in the context of a capital increase completed on October 20, 2023, the Company&rsquo;s share capital has increased from EUR&nbsp;163,471,629.58
to EUR 164,302,752.89 and the number of issued and outstanding shares has increased from 270,380,936 to 272,880,936 ordinary shares, through
the issuance of a total of 2,500,000 new shares. The new shares were issued pursuant to the amendment, announced on August 23, 2023, to
the asset purchase agreement for the acquisition by the Company of the Oncotype DX&reg; GPS (Genomic Prostate Score&reg;) test from Genomic
Health, Inc. (a subsidiary of Exact Sciences Corporation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the outstanding shares of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            total of 18,560,124 subscription rights of the Company are outstanding, which entitles their
                                            holders (assuming all subscription rights are granted and exercised) to subscribe to a total
                                            of 18,560,124 new shares with voting rights; and</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">under
                                            </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the loan and security agreement
                                            entered into by the Company and Innovatus Capital Partners in August 2022, Innovatus has
                                            the right to convert, prior to August 2, 2025, up to 15% of the outstanding principal amount
                                            of the loans (by means of a contribution in kind of the relevant payables due by the Company
                                            under the loans) into American Depositary Shares (&ldquo;<B>ADSs</B>&rdquo;) of the Company
                                            (each representing 10 ordinary shares of the Company) at a conversion price per ADS equal
                                            to USD 11.21 (i.e., USD 1.121 per share on the basis of the ratio of 1 ADS per 10 shares).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About mdxhealth<SUP>&reg;</SUP></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">mdxhealth is a commercial-stage precision diagnostics
company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company&rsquo;s tests are based
on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis
of urologic cancers and other urologic diseases. The Company&rsquo;s U.S. headquarters and laboratory operations are in Irvine, California,
with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen,
The Netherlands. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth
and linkedin.com/company/mdxhealth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For more information:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 59%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>mdxhealth </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">info@mdxhealth.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="width: 41%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>LifeSci Advisors (IR &amp; PR)</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">US: +1-949-271-9223</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@mdxhealth.com</P></TD>
    <TD STYLE="font-size: 10pt; text-underline-color: #434343; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>NOTE:</I></B><I> The mdxhealth logo, mdxhealth,
Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate Score, GPS and Monitor mdx are trademarks or registered trademarks of MDxHealth
SA. All other trademarks and service marks are the property of their respective owners.</I></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  F 0$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BL[6-=T
M_0;47&H7 C4G"*!EG/H!WKF1\3+ $22:7J4=L3Q.8AC'KUIV;$VD=O15&RUC
M3]0TW^T+:ZC>U ):0G 7'7=GI^-<U<?$C3!</%8V=]?A/O201?+^O/Z46871
MV=%8.A>+]*\02&&VD>*Z49-O,NU_?'8_A6]2&G<**P]<\6Z1X?81WDY:<C(@
MB&Y\?3M^-9,'Q)TAI56ZM;ZT1C@231?+^A)IV8KH37+JXC^).@6Z3RK#)$Q>
M-7(5N'ZCH:[.N"U>>&Z^)/AJ>"1)8I(69'0Y###]#71>*=2O=+TC[18QAGW@
M,Q&=BX/./K@?C5Q@Y-174QJUHT:<JLMEKH;=%<]X7\2IK=N8IMJ7D8RRC@,/
M4?UK?DD2&)I)&"HHRS'H!2J0=.3C(,/B*>(IJK3=TQU<SX_GFMO!MY+!+)%(
M&CP\;%2/G7N*JQ>*KR]UZ."SA#6Q<+M*\E<\L3V]:F^(W_(D7O\ O1_^AK6%
M*K&H_=Z%J:DG8W-&=I-"T]W8LS6T9+,<DG:.35ZN2'B_2="T;3+>XDDENC:1
M'R(%W/\ <'7L*9:?$C19[E8+J.ZL68\&XCPOXD$XK6S*YD=A12*RNH92&4C(
M(.016?J^N:=H5L)]0N5B4\*O5F/L!R:11HT5QG_"R=-!WOIVII;'_ENT V_S
MKJ-.U.SU:S6[L;A)H6XW+V/H1V/M3LT)-,MT4C,J*68A5 R23@ 5R5Y\1M%M
M[EH+5+F_=>IMH\K^9(S^%"5P;2.NHKG-&\;:/K-T+1'EMKL](;A=I8^@[$^W
M6K^BZ]9ZZER]HLH%O*8G\Q0/F'IR:+,+HY\W5Q_PMA;;SY?L_P!BW>5O.W..
MN.E=I7#-_P EB7_KQ_I6QK?C'3M!OA:74-V\A0/F*,,,$D=<CTIM"3M>Y?T?
M7++78)IK%G9(I#&VY=OS8!_K6E7DO@GQCIVB6%[%<PW;M+=-(OE1A@ 0!SSU
MXKM-*\<Z7J^I0V-O!>K++G:9(@%& 3R<^U#0*291\;W5Q;ZWX92">6)9+S:Z
MHY4.-R<''7J:[2N&\>_\A[PK_P!?O_LT=7]2\?Z/8W3VL*W%]-&<.+5-P4_4
MD?I1;1"O9NYU5%<UHWCK1M9NA:(\MM=,<+%<+M+'T!R1GVK5NM3^S7'E"+>!
MU.[';)Q^%*Q5T:%%0_:HO4_E12&<-HMI'XH\:ZMJFH*)H=/E^SVL+\J""1G'
MX9^I]J[UD1T*,H9",%2,@BN*^'__ !^>)/\ L(/_ #:NWIO<F.QY/X@\.-:>
M,;?1M/G>WTW5V5Y84/RC:3G _4?6O3[&PM=-M$M;.!(84& JC'XGU/O7(^(O
M^2D^&O\ =D_D:[>FWL$5JSBO'^CQKIW]OV8$&I6+JXE3@LN0,'UQG/Z=ZV[C
M71#X/.N;!DV@G5>VXJ,#\R*A\<?\B7J?_7,?^A"J+6,FI?"R*UA!:5].C**.
MY"@@?I1T#J[%?P)H$1L%U_4%%QJ5Z3+YDG)12>,>A/7/OBNRGMX;J%H;B))8
MG&&1U!!_"N=\!:G#J/A.S2-AYMJ@@E3NI7@?F,&NFI/<(['E@T3^POBEI5M"
M[FR?=+;H3D1@JV5'X@_G7J3*KJ58!E(P01D$5YUJ>J07_P 6])MX&#BT5HW8
M'^,JQ(_#C\<UZ%/<16L#SSR+'$@RS,< 4W?02MJ<3K?AB?2KG^U]$)7RSO:(
M?P^I'J/:DEU:]\6K!96D1B3:&G.>,]SGTJGJ>O7WBS4!I.DAH[5C\S="P[EO
M0>W_ .JM*]\/2>'K>"\TJ23,"XEYY/JWT]J>/<W02GOU[V//P6"I^WG[&7+"
M73IS>78Z/2-%MM(M]D0W2L/GD(Y/^ K'^(W_ "(]]_O1_P#H:UH:'X@@U:/R
MWQ'=*.4[-[C_  K/^(W_ ")%[_O1_P#H:UC1<'%<FQZ<Z;IWBU8?X)T&VTO0
M;6Y*![VYB6669N6Y&0H/H!@5JZWHMIKNFRVEU$K;E.QR.4;L0>U/T/\ Y &F
M_P#7K%_Z"*OUHWJ)+2QQOPTO9KCPL8)V+&TG:%23_#@$#\,FLOP[]C\2^)-0
MU[5IH6C@E\FS@E<84#O@^V/Q)JY\,!G1-1![WK?^@K6)X0\,Z+>7VJZ5J]KN
MU"UG)7,C*6CZ9 !YYY_X$*KN1T1Z6U]8,A1KJV*D8(,BX(KAX#;>&OB';1:=
M+'_9VK*0\,; JD@Z8 Z<X_[Z-;7_  KSPQ_T#S_W_?\ QJ6S\$^'+&_BN+>S
MV7,)$B?OG)&#P<$TM"FFS+\?75S>7&F>&[20QMJ,G[YQV0'I].I_"NITK1['
M1;)+6Q@6)%&"0/F<^K'N:Y'QLQTKQ3H&NR*3:Q.896'\.?\ ZQ;\J[I'62-7
M1@R, 58'((/>A[ MV9'B'P[::]8NCHJ7:#,%PO#QL.G/7&>U<U\*Q*-+U,3$
MF47AWYZYVC-=M?WL&G6,UY<N$AA0LQ/\OK7%?"V<W.FZK.1@R7A?'IE0:.@/
MXD2-_P EB7_KQ_I7<UPS?\EB7_KQ_I7<TF$>IPWPP_Y!6I_]?S?^@K7<UPOP
MQ(&GZK&>'6];*]QP/\#7=42W".QYY\3K>2[N_#UO$Y226X>-7'\))09_6NUT
MK2;+1K&.TLH5CC4 $@<L?4GN:Y3Q[_R'O"O_ %^_^S1UW--[(%NSCOB)HMM=
M^'9M15%2]M,2),HPV,@$$_K^%;.ALFKZ#I]]<INFFMT,AR1N..X[\^M0^-?^
M1-U3_KC_ %%/\'_\BAI7_7NM'0/M&W@>E%%%24<_X9T"XT2?59)Y8Y!>733)
MLS\H))P<_6N@HHH$E8Y_5- N+[Q7I.K)+$L5D&#HV=S9ST_.N@HHH"QF>(=-
MEUC0+O3X71))U"JSYP.0>WTJ;1[)].T:RLI&5GMX$C9EZ$@ <444!;J<WJ?@
MJ>/5)-5\.:@=.NY#F2,C,;GZ=OR(J :7XVU)3;W>NV=O >'>V0[R/;Y1C\Q1
M13N+E1+;>!(].U[2;RPDC6"S5O-\S)DE8YRQ.,=Q^5;7B71'U[3%MHY_)=9
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+HH"W4T****!G_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
